Paper published in a journal (Scientific congresses and symposiums)
A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates
Miller, P.; Pannacciulli, N.; Brown, J.P.et al.
2016 • In Osteoporosis International, 27 (SUPPLEMENT1), p. 42
A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates.pdf
A randomized double-blind study of Denosumab (DMAB) compared with Zoledronic acid (ZOL) in postmenopausal women with osteoporosis previously treated with oral bisphosphonates
Publication date :
April 2016
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Event organizer :
WCO-IOF-ESCEO
Event place :
Malaga, Spain
Event date :
du 14 au 17 avril 2016
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
